Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,716 | 11,433 | 8,906 | 3,816 | 5,930 |
| Marketable Securities | 3,593 | 5,933 | 550 | 25,264 | 31,471 |
| TOTAL | $19,579 | $17,656 | $9,799 | $29,505 | $38,239 |
| Non-Current Assets | |||||
| PPE Net | 20 | 25 | 38 | 52 | N/A |
| Investments And Advances | 0 | 0 | 0 | 539 | 9,486 |
| Other Non-Current Assets | 176 | 63 | 65 | 60 | 47 |
| TOTAL | $196 | $88 | $103 | $651 | $9,533 |
| Total Assets | $19,775 | $17,744 | $9,902 | $30,156 | $47,772 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,304 | 1,115 | 916 | 549 | 550 |
| Accrued Expenses | 1,232 | 1,516 | 2,362 | 2,665 | 1,001 |
| Other current liabilities | 316 | 350 | 222 | 295 | 273 |
| TOTAL | $2,862 | $2,994 | $3,513 | $3,521 | $1,824 |
| Non-Current Liabilities | |||||
| TOTAL | $6 | $16 | $29 | $42 | $N/A |
| Total Liabilities | $2,868 | $3,010 | $3,542 | $3,563 | $1,824 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,763 | 48,473 | 34,732 | 22,704 | 22,694 |
| Common Shares | 50 | 40 | 26 | 23 | 23 |
| Retained earnings | -130,072 | -110,011 | -98,438 | -73,565 | -53,472 |
| Other shareholders' equity | -6,102 | -117 | -353 | -879 | -1,964 |
| TOTAL | $16,907 | $14,734 | $6,360 | $26,593 | $45,948 |
| Total Liabilities And Equity | $19,775 | $17,744 | $9,902 | $30,156 | $47,772 |